The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-18 of 18 articles
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study
Bor W,
de Veer AJW,
Olie R,
Rikken S,
Chan Pin Yin D,
Herrman JP,
Vrolix M,
Meuwissen M,
Vandendriessche T,
van Mieghem C,
Magro M,
Bennaghmouch N,
Hermanides R,
Adriaenssens T,
Dewilde W,
ten Berg J
July 22, 2022 | 10.4244/EIJ-D-21-00703
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S,
Vrolix M,
Montorfano M,
Zivelonghi C,
Giannini F,
Bedogni F,
Dubois C,
De Bruyne B,
Costa R,
Chamié D,
de Ribamar Costa J,
Kereiakes D,
Abizaid A,
Colombo A
December 18, 2020 | 10.4244/EIJ-D-20-00763
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabate M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg PG,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabate M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial
von Birgelen C,
Asano T,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska JJ,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Onuma Y,
Serruys P,
Sabate M
April 20, 2018 | 10.4244/EIJ-D-17-00462
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Kandzar D,
Donohoe D,
Ormiston J
April 6, 2018 | 10.4244/EIJ-D-17-00230
COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial
Dubois C,
Bennett J,
Dens J,
De Cock D,
Desmet W,
Belmans A,
Ughi G,
Sinnaeve P,
Vrolix M,
D’hooge J,
Adriaenssens T
April 20, 2016 | 10.4244/EIJY15M05_02
STENTYS Self-Apposing® sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial
van Geuns R,
Yetgin T,
La Manna A,
Tamburino C,
Souteyrand G,
Motreff P,
Koch K,
Vrolix M,
IJsselmuiden A,
Amoroso G,
Berland J,
Montalescot G,
Teiger E,
Christiansen E,
Spaargaren R,
Wijns W
February 12, 2016 | 10.4244/EIJV11I11A248
Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study
Nakatani S,
Onuma Y,
Ishibashi Y,
Karanasos A,
Regar E,
Garcia-Garcia H,
Tamburino C,
Fajadet J,
Vrolix M,
Witzenbichler B,
Eeckhout E,
Spaulding C,
Reczuch K,
La Manna A,
Spaargaren R,
Capodanno D,
van Langenhove G,
Verheye S,
Serruys P,
van Geuns R
December 20, 2015 | 10.4244/EIJY15M11_01
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial
Dewilde W,
Janssen P,
Kelder J,
Verheugt F,
de Smet B,
Adriaenssens T,
Vrolix M,
Brueren G,
Vandendriessche T,
van Mieghem C,
Cornelis K,
Vos J,
Breet N,
ten Berg J
August 20, 2015 | 10.4244/EIJY14M06_07
Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial
Adriaenssens T,
Dens J,
Ughi G,
Bennett J,
Dubois C,
Sinnaeve P,
Wiyono S,
Coosemans M,
Belmans A,
D’hooge J,
Vrolix M,
Desmet W
August 19, 2014 | 10.4244/EIJV10I4A77
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial
Legrand V,
Cuisset T,
Chenu P,
Vrolix M,
Martinez C,
Dens J,
Gach O,
Boland J,
Claeys M,
Magne J,
Barbato E,
Wijns W
June 20, 2014 | 10.4244/EIJV10I2A34
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023